## CHRW: C.H. Robinson Worldwide, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 3.3% below STRENGTH zone (4.0-10.0%); PEG 2.32 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($157.29)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Bullish (Bullish: 1, Bearish: 1)

**1. Thrivent Financial for Lutherans Boosts Holdings in C.H. Robinson Worldwide, Inc. $CHRW**
- Source: MarketBeat | 20251221T110738 | Somewhat-Bullish | Relevance: 100%
- Thrivent Financial for Lutherans has significantly increased its stake in C.H. Robinson Worldwide, Inc. by 865.4%, bringing its total holdings to 47,015 shares valued at $4.51 million. This comes despite insider sell-offs from two executives, Angela K. Freeman and Michael D. Castagnetto, who collectively reduced their positions by over 40%. Analysts currently rate C.H. Robinson Worldwide as a "Moderate Buy" with an average price target of $147.48, and the company recently raised its quarterly dividend to $0.63.

**2. C.H. Robinson Worldwide Stock Surges 6.0%, With A 5-Day Winning Spree**
- Source: Trefis | 20251220T060737 | Bullish | Relevance: 100%
- C.H. Robinson Worldwide (CHRW) stock has surged by 6.0%, marking its fifth consecutive day of gains. This article highlights the recent positive performance of the company's stock in the market.

**3. Is It Too Late To Consider C.H. Robinson After Its Strong 2025 Share Price Rally?**
- Source: Yahoo Finance | 20251222T100906 | Bearish | Relevance: 100%
- C.H. Robinson Worldwide has seen significant share price growth in 2025, outpacing the market, driven by optimism around freight efficiency and digital logistics. However, valuation checks suggest the stock is currently overvalued, with its DCF analysis indicating a 14.2% overvaluation and its PE ratio sitting well above industry averages and its proprietary Fair Ratio. Investors are encouraged to consider different "Narratives" for valuation to align with their own views on the company's future.

**4. Board of the Pension Protection Fund Trims Stock Position in C.H. Robinson Worldwide, Inc. $CHRW**
- Source: MarketBeat | 20251220T095641 | Somewhat-Bullish | Relevance: 96%
- The Board of the Pension Protection Fund significantly cut its stake in C.H. Robinson Worldwide by 85.1% in Q3, now owning 2,100 shares valued at $278,000. Additionally, company insiders Angela K. Freeman and Michael D. Castagnetto sold substantial amounts of shares in early November. Despite these sales, analysts generally maintain a "Moderate Buy" rating for CHRW, with the company having recently beaten Q3 EPS estimates and raised its quarterly dividend.

**5. Investors See Strong Returns with AIRR ETF as Onshoring Gains Traction**
- Source: cointurk finance | 20251222T170941 | Somewhat-Bullish | Relevance: 72%
- The First Trust RBA American Industrial Renaissance ETF (AIRR) has delivered significant returns, achieving a 30% return in 2025, driven by strategic investments in small and mid-cap industrial companies benefiting from U.S. onshoring initiatives. Key holdings like Comfort Systems USA surged, highlighting the fund's capacity to capitalize on macroeconomic trends. The ETF's future performance remains heavily influenced by tariff policies and domestic production incentives.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Stifel | $184 | $155 | +19% |
| 2025-12-16 | Barclays | $200 | $145 | +38% |
| 2025-12-08 | Morgan Stanley | $85 | $77 | +10% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Stifel | main | Buy |
| 2025-12-16 | Barclays | up | Overweight |
| 2025-12-08 | Morgan Stanley | main | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 4 ($1.86M) |
| Sells | 2 ($0.38M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 54.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.0% (-3.0%)
- First Eagle Investme: 8.9% (-0.2%)
- Blackrock Inc.: 8.2% (-8.5%)
- Wellington Managemen: 6.1% (+198.6%)
- State Street Corpora: 5.8% (-7.4%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 3 raises (avg +22%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +1.2% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.32 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 34%). Analyst sentiment positive (3 raises, avg +22%). Insider buying signal ($1.9M), management confidence. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $19.5B |
| Beta | 0.91 |
| 52W Range | $84.68 - $167.90 |
| Short Interest | 7.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.32 |
| Forward P/E | 27.5 |
| Current P/E | 33.1 |
| YoY Growth | 20.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 2.1% to 3.3% (+1.2% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.7pp (needs >4.0% for momentum thesis). MRS_5 (-0.2%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 4.0% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). Elevated volume (1.9x 20MA), institutional activity likely. OFD pattern: -STN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.33% (CS: 75) | Neutral |
| RSI_14 | 66.3 | Neutral |
| MACD Histogram | 0.27 | Bullish |
| vs SMA20 | 1.038x | Above |
| vs SMA50 | 1.113x | Above |
| vs SMA200 | 1.411x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $164.99
- **Stop Loss:** $157.29 (4.7% risk)
- **Target:** $172.69 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 116
- **Position Value:** $19,138.84
- **Portfolio %:** 19.14%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-01-28 (Est: $1.13)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.30 | $1.40 | +7.4% |
| 2025Q2 | $1.16 | $1.29 | +11.6% |
| 2025Q1 | $1.05 | $1.17 | +11.4% |
| 2024Q4 | $1.11 | $1.21 | +9.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*